ADVANCED BILE DUCT CARCINOMA
Clinical trials for ADVANCED BILE DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILE DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILE DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
Experimental pill aims to boost radiation against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it makes tumor cells more sensitive to radiation therapy. Nineteen participants with cancer…
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC